Esperite N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 27 feb 2019 - 07:17
  • Statutory name Esperite N.V.
  • Title Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia.

Related downloads

201902270000000005_Esperite (ESP) with The Cell Factory has confirmed a longterm....pdf

Date last update: 10 December 2019

Share information

Share on: Share this